Effect of psoriasis activity on VEGF and its soluble receptors concentrations in serum and plaque scales

Cytokine

Volumn 61, Issue 2, 2013, Pages 690-

  Flisiak, Iwona ^a   Zaniewski, Przemysław ^a   Rogalska, Magdalena ^a   Myśliwiec, Hanna ^a   Jaroszewicz, Jerzy ^a   Chodynicka, Bozena ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

VASCULOTROPIN; VASCULOTROPIN RECEPTOR;

DEGRANULATION; DISEASE ACTIVITY; DISEASE DURATION; DISEASE EXACERBATION; HUMAN; LETTER; PRIORITY JOURNAL; PSORIASIS; SCORING SYSTEM;

FEMALE; HUMANS; MALE; PSORIASIS; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1;

EID: 84873106524     PISSN: 10434666     EISSN: 10960023     Source Type: Journal    
DOI: 10.1016/j.cyto.2012.11.012     Document Type: Letter

References (3)

1. Batycka-Baran A, Krawczenko A, Paprocka M, Baran W, Kantor A, Duś D, et al. The soluble vascular endothelial growth factor receptor-1 (sVEGFR-1) in patients with plaque psoriasis - does it play any role? Cytokine 2013;61:688-9.
2. Flisiak I., Zaniewski P., Rogalska M., MyŚliwiec H., Jaroszewicz J., Chodynicka B. Effect of psoriasis activity on VEGF and its soluble receptors concentrations in serum and plaque scales. Cytokine 2010, 52:225-229.
3. Flisiak I., Zaniewski P., Rogalska-Taranta M., Chodynicka B. Effect of psoriasis therapy on VEGF and its soluble receptors serum concentrations. J Eur Acad Dermatol Venereol 2012, 26:302-307.